Cancer Genomic Testing Market
Cancer Genomic Testing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cancer
Genomic Testing Market Size and Growth
The Cancer Genomic Testing market is experiencing substantial growth, driven by increased cancer incidence and advancements in genomic technologies. The global market size is projected to reach approximately $18 billion by 2027, reflecting a CAGR of around 10%. Enhanced diagnostic capabilities and personalized medicine continue to propel market conditions favorably. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Myriad Genetics
◍ Centogene AG
◍ Color Genomics
◍ Quest Diagnostics
◍ 23andMe Inc.
◍ Gene By Gene Ltd.
◍ LabCorp
◍ Positive Bioscience
◍ Bio-Rad Laboratories
◍ Illumina, Inc.
◍ Agilent Technologies
◍ Thermo Fisher Scientific
The cancer genomic testing market features key players like Myriad Genetics, LabCorp, and Illumina. These companies enhance testing accessibility, innovate technologies, and foster partnerships to expand applications. Revenue highlights include Myriad Genetics with $844 million, LabCorp at $3.1 billion, and Illumina reaching $4.5 billion.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
◍ Diagnostic Laboratories
◍ Academic and Research Institutes
◍ Others
By Product
◍ Breast Cancer Genomic Testing
◍ Lung Cancer Genomic Testing
◍ Blood Cancer Genomic Testing
◍ Liver Cancer Genomic Testing
◍ Stomach Cancer Genomic Testing
◍ Others
Request Sample Report
$ 56.53 Billion
Request Sample Report
